
Health officials investigating whether vaccine causes blood clots
Health Canada is keeping tabs on European investigations into the Oxford-AstraZeneca vaccine after overseas reports of some recipients developing blood clots following inoculations.
For now, the government agency is assuring Canadians that the ''benefits of the vaccine continue to outweigh its risks.''
It says it authorized the vaccine for Canadian use based on a thorough review.
At least nine European countries as well as, Thailand, have temporarily suspended their use of AstraZeneca's doses pending investigation of blood clots, though none suggest there is a link between the two.